References
- Cossart YE, Cant B, Field AM, Widdows D. Parvovirus-like particles in human sera. Lancet 1975; 1: 72–3.
- Anderson MJ, Lewis E, Kidd IM, Hall SM, Cohen BJ. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg Camb 1984; 93: 85–93.
- Chorba T, Coccia P, Holman RC, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (Fifth Disease). J Infect Dis 1986; 154: 383–93.
- Kurtzman GI, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infections. N Engl J Med 1987; 317: 287–94.
- Gray ES. Parvovirus B19 infections in the fetus, newborn and child. Curr Opin Infect Dis 1991; 4: 485–90.
- Reid DM, Reid TMS, Brown T, Rennie JAN, Eastmond CJ. Human parvovirus associated arthritis: A clinical and laboratory description. Lancet 1995; 1: 422–5.
- Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151–3.
- Schwarz TF, Roggerdorf M, Deinhardt F. Prevalence of parvovirus B19 infection: A sero-epidemiological study. Dtsch Med Wochenschr 1987; 112: 1526–31.
- Matsunaga Y, Goh KT, Utagawa E, Muroi N. Low prevalence of antibody to human parvovirus B19 in Singapore. Epidemiol Infect 1994; 113: 537–40.
- Yamashita K, Matsunaga Y, Taylor Wiedeman J, Yamazaki S. A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med Sci Biol 1992; 45: 45–58.
- Cohen BJ, Mortimer PP, Pereira MS. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg 1983; 91: 113–30.